Porto Cancer Meeting brings together world experts in the Council Chambers

More than 200 cancer researchers gathered in the city to discuss and share experiences in the area. At the end of the event, some of the world’s leading experts who were present in the 28th edition of the Porto Cancer Meeting were received at the Council Chambers.

The Mayor of Porto, Rui Moreira, welcomed a delegation led by the physician and researcher from Porto, Manuel Sobrinho-Simões and by the scientist from i3S and member of the organizing committee of the meeting, Sónia Melo.

The director of i3S, Claudio Sunkel, the director of Pathological Anatomy service at Hospital de São João, Fátima Carneiro, the vice-president of the Institute of Pathology and Molecular Immunology of the University of Porto (IPATIMUP), José Carlos Machado, the researcher specializing in Molecular Oncobiology, André Albergaria, the researcher of the “Cancer Signaling & Metabolism” group at i3S-IPATIMUP, Jorge Lima, the president of the International Society of Extracellular Vesicles, Clotilde Thery, the researcher from the University of Pennsylvania, Wei Guo, the scientific director of the North American Codiak Biosciences, Sriram Sathyanarayanan, the pathologist at Cedars-Sinai Hospital, Dolores Di Vizio, the professor at the Swiss Federal Institute of Technology (EPFL), Michele De Palma, the French biologist Jacky Goetz, MD Anderson Cancer Center Investigator Raghu Kalluri, InGenesis Scientific Director, Valerie LeBleu, IPO oncologist, Júlio Oliveira and the researcher, Carolina Ruivo.

Focused “on the intercellular communication network that links all the cellular components of cancer, with a focus on extracellular vesicles”, this year’s Porto Meeting Cancer , organized by the Instituto de Investigação e Inovação em Saúde of the University of Porto (i3S), dedicated two intensive days to conferences and debates on the “function of these vesicles in cancer biology, in the host’s immune response and also in the most recent and innovative therapies in cancer based in extracellular vesicles”.

The aim, says the organization, was to “debate the latest findings from the basic biology to the clinical translational component of the mechanism used by cancer cells to communicate with neighboring cells and cells in distant organs”.